학술논문

A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trial
Document Type
Article
Source
In: BMC Cancer. (BMC Cancer, December 2024, 24(1))
Subject
Language
English
ISSN
14712407